Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter R Flatt

Showing results (31-40 of 325) with videos related to

Pageof 33
Sort By:
The British Journal of Nutrition|January 21, 2012
Evaluation of the long-term effects of gastric inhibitory polypeptide-ovalbumin conjugates on insulin resistance, metabolic dysfunction, energy balance and cognition in high-fat-fed miceNigel Irwin, Ian A Montgomery, Peter R Flatt
Journal of Experimental Zoology. Part A, Comparative Experimental Biology|August 12, 2006
Major contributions of comparative endocrinology to the development and exploitation of the incretin conceptJ Michael Conlon, Steven Patterson, Peter R Flatt
Current Opinion in Endocrinology, Diabetes, and Obesity|January 4, 2021
Established and emerging roles peptide YY (PYY) and exploitation in obesity-diabetesRyan A Lafferty, Peter R Flatt, Nigel Irwin
Peptides|June 2, 2024
NPYR modulation: Potential for the next major advance in obesity and type 2 diabetes management?Ryan A Lafferty, Peter R Flatt, Nigel Irwin
Biochimica Et Biophysica Acta|February 18, 2015
Functional GIP receptors play a major role in islet compensatory response to high fat feeding in miceR Charlotte Moffett, Srividya Vasu, Peter R Flatt
Expert Opinion on Pharmacotherapy|March 17, 2023
GLP-1/GIP analogs: potential impact in the landscape of obesity pharmacotherapyRyan A Lafferty, Peter R Flatt, Nigel Irwin
Archives of Biochemistry and Biophysics|March 23, 2007
Major metabolic homocysteine-derivative, homocysteine thiolactone, exerts changes in pancreatic beta-cell glucose-sensing, cellular signal transduction and integritySteven Patterson, Peter R Flatt, Neville H McClenaghan
Peptides|September 23, 2021
Recent advances in peptide-based therapy for Type 2 diabetes and obesityJ Michael Conlon, Peter R Flatt, Clifford J Bailey
Frontiers in Endocrinology|December 3, 2021
Editorial: Proglucagon-Derived PeptidesPeter R Flatt, Filip K Knop, Andrei I Tarasov
Biochemical Pharmacology|December 14, 2004
Alterations of insulin secretion following long-term manipulation of ATP-sensitive potassium channels by diazoxide and nateglinideAndrew J Ball, Peter R Flatt, Neville H McClenaghan
Pageof 33

Showing results (31-40 of 325) with videos related to

Sort By:
Pageof 33
The British Journal of Nutrition|January 21, 2012
Evaluation of the long-term effects of gastric inhibitory polypeptide-ovalbumin conjugates on insulin resistance, metabolic dysfunction, energy balance and cognition in high-fat-fed miceNigel Irwin, Ian A Montgomery, Peter R Flatt
Journal of Experimental Zoology. Part A, Comparative Experimental Biology|August 12, 2006
Major contributions of comparative endocrinology to the development and exploitation of the incretin conceptJ Michael Conlon, Steven Patterson, Peter R Flatt
Current Opinion in Endocrinology, Diabetes, and Obesity|January 4, 2021
Established and emerging roles peptide YY (PYY) and exploitation in obesity-diabetesRyan A Lafferty, Peter R Flatt, Nigel Irwin
Peptides|June 2, 2024
NPYR modulation: Potential for the next major advance in obesity and type 2 diabetes management?Ryan A Lafferty, Peter R Flatt, Nigel Irwin
Biochimica Et Biophysica Acta|February 18, 2015
Functional GIP receptors play a major role in islet compensatory response to high fat feeding in miceR Charlotte Moffett, Srividya Vasu, Peter R Flatt
Expert Opinion on Pharmacotherapy|March 17, 2023
GLP-1/GIP analogs: potential impact in the landscape of obesity pharmacotherapyRyan A Lafferty, Peter R Flatt, Nigel Irwin
Archives of Biochemistry and Biophysics|March 23, 2007
Major metabolic homocysteine-derivative, homocysteine thiolactone, exerts changes in pancreatic beta-cell glucose-sensing, cellular signal transduction and integritySteven Patterson, Peter R Flatt, Neville H McClenaghan
Peptides|September 23, 2021
Recent advances in peptide-based therapy for Type 2 diabetes and obesityJ Michael Conlon, Peter R Flatt, Clifford J Bailey
Frontiers in Endocrinology|December 3, 2021
Editorial: Proglucagon-Derived PeptidesPeter R Flatt, Filip K Knop, Andrei I Tarasov
Biochemical Pharmacology|December 14, 2004
Alterations of insulin secretion following long-term manipulation of ATP-sensitive potassium channels by diazoxide and nateglinideAndrew J Ball, Peter R Flatt, Neville H McClenaghan
Pageof 33